GENETIC POLYMORPHISM

GENETIC POLYMORPHISM was reported 57 times

GENETIC POLYMORPHISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 16 0.0007
1 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 24 0.0005
2 Cytomegalovirus pUL97 Kinase Inhibitor [EPC] 1 0.0004
3 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 25 0.0002
4 Antiparasitic [EPC] 1 0.0002
5 Pediculicide [EPC] 1 0.0002
6 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
7 Complement Inhibitor [EPC] 3 0.0001
8 Human Immunoglobulin G [EPC] 1 0.0000
9 Protease Inhibitor [EPC] 2 0.0000
10 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
11 Provitamin D2 Compound [EPC] 1 0.0000
12 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
13 Sympathomimetic-like Agent [EPC] 1 0.0000
14 Mood Stabilizer [EPC] 6 0.0000
15 Anti-epileptic Agent [EPC] 6 0.0000
16 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
17 Topoisomerase Inhibitor [EPC] 1 0.0000
18 Nucleoside Analog Antiviral [EPC] 1 0.0000
19 Atypical Antipsychotic [EPC] 5 0.0000
20 Benzodiazepine [EPC] 7 0.0000
21 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
22 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
23 Calcium [EPC] 1 0.0000
24 Azole Antifungal [EPC] 1 0.0000
25 Estrogen [EPC] 1 0.0000
26 RANK Ligand Inhibitor [EPC] 1 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
28 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
29 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
30 Loop Diuretic [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 1 0.0000
32 Corticosteroid [EPC] 2 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000